Clinical Trial Update: IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing IMRT with carboplatin versus IMRT with carboplatin and fluorouracil in elderly esophageal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• FLUOROURACIL (Fluorouracil)
• IMRT

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Cancer, Radiotherapy Side Effect | Phase 2 | Status: UNKNOWN